Investigation of Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816
Phase of Trial: Phase II
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 01 Aug 2017 Planned End Date changed from 21 Jul 2017 to 21 Jul 2018.
- 01 Aug 2017 Planned primary completion date changed from 21 Jul 2017 to 21 Jul 2018.
- 16 Jun 2015 New trial record